Scientific Clinical Laboratory Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.31 M
as on 10-12-2024
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1.39%
(FY 2020)
- Profit -14.77%
(FY 2020)
- Ebitda -1.64%
(FY 2020)
- Net Worth 15.12%
(FY 2020)
- Total Assets 13.87%
(FY 2020)
About Scientific Clinical Laboratory
The Corporate was formerly known as Scientific Clinical Research Lab Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.31 M, as per Ministry of Corporate Affairs (MCA) records.
Nandini Basu, Rupasree Dutta, and Samudra Basu serve as directors at the Company.
- CIN/LLPIN
U85195WB1986PTC040265
- Company No.
040265
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Scientific Clinical Laboratory?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandini Basu  | Director | 28-Feb-1986 | Current |
| Rupasree Dutta | Director | 22-Aug-1999 | Current |
| Samudra Basu | Director | 20-Jun-2019 | Current |
Financial Performance of Scientific Clinical Laboratory.
Scientific Clinical Laboratory Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.39% increase. The company also saw a substantial fall in profitability, with a 14.77% decrease in profit. The company's net worth Soared by an impressive increase of 15.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scientific Clinical Laboratory?
In 2020, Scientific Clinical Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Beta Clinical Laboratory Pvt LtdActive 36 years 6 monthsNandini Basu and Rupasree Dutta are mutual person
- Ns Scientific Immunoassay Pvt LtdActive 32 years 1 month
Nandini Basu, Rupasree Dutta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Scientific Clinical Laboratory?
Scientific Clinical Laboratory has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scientific Clinical Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scientific Clinical Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
